Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Repeated dose toxicity information is only available for the oral administration route.
Oral administration of RSS-4 dry substance to HanIbm Wistar rats for 13 weeks was associated with changes in the kidney and liver at concentrations of 10000 or 30000 ppm and reduced weight gain, food intake and food conversion efficiencies.

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Dose descriptor:
NOAEL
241.7 mg/kg bw/day
Study duration:
subchronic
Species:
rat

Additional information

Only one study addressing oral repeated dose toxicity is available. The study consists of a 2 -week preliminary study (1997, Klimish rating K3, supporting study) addressing palatability and dose selection, and a 90-day main study (1997, Klimish rating K1, key study).

Both studies are performed according to GLP. The key study has a well described protocol and testing conditions. However, no internationally accepted protocol (e.g. OECD) mentioned in the study report, but the applied protocol is highly similar to OECD 408. Neurobehaviour is not examined in this repeated dose study.

The study shows that administration of RSS-4 dry substance to HanIbm Wistar rats for 13 weeks was associated with changes in the kidney and liver at concentrations of 10000 or 30000 ppm and reduced weight gain, food intake and food conversion efficiencies.

The NOAEL in this study was 3000 ppm as a nominal dietary concentration, which corresponds to 241.7 mg/kg bw/d for male animals and 277.7 mg/kg bw/d for female animals.


Repeated dose toxicity: via oral route - systemic effects (target organ) digestive: liver; urogenital: kidneys

Justification for classification or non-classification

Based on the results from this study, no classification (EC1272/2008) is required.